Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists

Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) have emerged as novel therapeutic agents...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Veronika A. Myasoedova, Michele Bozzi, Vincenza Valerio, Donato Moschetta, Ilaria Massaiu, Valentina Rusconi, Daniele Di Napoli, Michele Ciccarelli, Valentina Parisi, Piergiuseppe Agostoni, Stefano Genovese, Paolo Poggio
Format:	Artigo
Język:	Inglês
Wydane:	MDPI AG 2023-12-01
Seria:	Antioxidants
Hasła przedmiotowe:	sodium-glucose cotransporter 2 inhibitors glucagon-like peptide 1 receptor agonists cardio-metabolism oxidative stress inflammation fibrosis
Dostęp online:	https://www.mdpi.com/2076-3921/13/1/16
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!